170 related articles for article (PubMed ID: 22898898)
1. Insertion of a nuclear factor kappa B DNA nuclear-targeting sequence potentiates suicide gene therapy efficacy in lung cancer cell lines.
Cramer F; Christensen CL; Poulsen TT; Badding MA; Dean DA; Poulsen HS
Cancer Gene Ther; 2012 Oct; 19(10):675-83. PubMed ID: 22898898
[TBL] [Abstract][Full Text] [Related]
2. Targeted cytosine deaminase-uracil phosphoribosyl transferase suicide gene therapy induces small cell lung cancer-specific cytotoxicity and tumor growth delay.
Christensen CL; Gjetting T; Poulsen TT; Cramer F; Roth JA; Poulsen HS
Clin Cancer Res; 2010 Apr; 16(8):2308-19. PubMed ID: 20371678
[TBL] [Abstract][Full Text] [Related]
3. Single agent- and combination treatment with two targeted suicide gene therapy systems is effective in chemoresistant small cell lung cancer cells.
Michaelsen SR; Christensen CL; Sehested M; Cramer F; Poulsen TT; Patterson AV; Poulsen HS
J Gene Med; 2012 Jul; 14(7):445-58. PubMed ID: 22576955
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of secretory phospholipase A2 IIa reduces lung cancer growth in vitro and in vivo.
Yu JA; Mauchley D; Li H; Meng X; Nemenoff RA; Fullerton DA; Weyant MJ
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1185-91. PubMed ID: 23079010
[TBL] [Abstract][Full Text] [Related]
5. Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation.
Fiorentino FP; Tokgün E; Solé-Sánchez S; Giampaolo S; Tokgün O; Jauset T; Kohno T; Perucho M; Soucek L; Yokota J
Oncotarget; 2016 May; 7(21):31014-28. PubMed ID: 27105536
[TBL] [Abstract][Full Text] [Related]
6. MiR-335 regulates the chemo-radioresistance of small cell lung cancer cells by targeting PARP-1.
Luo Y; Tong L; Meng H; Zhu W; Guo L; Wei T; Zhang J
Gene; 2017 Feb; 600():9-15. PubMed ID: 27871924
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of TTF-1 binding DNA regions in small-cell lung cancer and non-small-cell lung cancer.
Hokari S; Tamura Y; Kaneda A; Katsura A; Morikawa M; Murai F; Ehata S; Tsutsumi S; Ishikawa Y; Aburatani H; Kikuchi T; Miyazono K; Koinuma D
Mol Oncol; 2020 Feb; 14(2):277-293. PubMed ID: 31782890
[TBL] [Abstract][Full Text] [Related]
8. Induction of cyclo-oxygenase-2 in non-small cell lung cancer cells by infection with DeltaE1, DeltaE3 recombinant adenovirus vectors.
Hirschowitz E; Hidalgo G; Doherty D
Gene Ther; 2002 Jan; 9(1):81-4. PubMed ID: 11850726
[TBL] [Abstract][Full Text] [Related]
9. Small interfering RNA-mediated suppression of serum response factor, E2-promotor binding factor and survivin in non-small cell lung cancer cell lines by non-viral transfection.
Walker T; Nolte A; Steger V; Makowiecki C; Mustafi M; Friedel G; Schlensak C; Wendel HP
Eur J Cardiothorac Surg; 2013 Mar; 43(3):628-33; discussion 633-4. PubMed ID: 23152437
[TBL] [Abstract][Full Text] [Related]
10. Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review.
Zarogoulidis P; Chatzaki E; Hohenforst-Schmidt W; Goldberg EP; Galaktidou G; Kontakiotis T; Karamanos N; Zarogoulidis K
Cancer Gene Ther; 2012 Sep; 19(9):593-600. PubMed ID: 22744209
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound microbubbles combined with the NFκB binding motif increase transfection efficiency by enhancing the cytoplasmic and nuclear import of plasmid DNA.
Deng Q; Chen JL; Zhou Q; Hu B; Chen Q; Huang J; Guo RQ
Mol Med Rep; 2013 Nov; 8(5):1439-45. PubMed ID: 24026477
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and application of poly(ethylene glycol)-co-poly(β-amino ester) copolymers for small cell lung cancer gene therapy.
Kim J; Kang Y; Tzeng SY; Green JJ
Acta Biomater; 2016 Sep; 41():293-301. PubMed ID: 27262740
[TBL] [Abstract][Full Text] [Related]
13. Targeting stanniocalcin-1-expressing tumor cells elicits efficient antitumor effects in a mouse model of human lung cancer.
Abe K; Kanehira M; Ohkouchi S; Kumata S; Suzuki Y; Oishi H; Noda M; Sakurada A; Miyauchi E; Fujiwara T; Harigae H; Okada Y
Cancer Med; 2021 May; 10(9):3085-3100. PubMed ID: 33826244
[TBL] [Abstract][Full Text] [Related]
14. XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer.
Kim J; McMillan E; Kim HS; Venkateswaran N; Makkar G; Rodriguez-Canales J; Villalobos P; Neggers JE; Mendiratta S; Wei S; Landesman Y; Senapedis W; Baloglu E; Chow CB; Frink RE; Gao B; Roth M; Minna JD; Daelemans D; Wistuba II; Posner BA; Scaglioni PP; White MA
Nature; 2016 Oct; 538(7623):114-117. PubMed ID: 27680702
[TBL] [Abstract][Full Text] [Related]
15. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of proliferation and apoptosis induced by a Na+/H+ exchanger-1 (NHE-1) antisense gene on drug-resistant human small cell lung cancer cells.
Li S; Bao P; Li Z; Ouyang H; Wu C; Qian G
Oncol Rep; 2009 May; 21(5):1243-9. PubMed ID: 19360300
[TBL] [Abstract][Full Text] [Related]
17. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.
Wiener Z; Ontsouka EC; Jakob S; Torgler R; Falus A; Mueller C; Brunner T
Exp Cell Res; 2004 Sep; 299(1):227-35. PubMed ID: 15302589
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
[TBL] [Abstract][Full Text] [Related]
19. Strategic targeting of non-small-cell lung cancer utilizing genetic material-based delivery platforms of nanotechnology.
Chaudhary S; Singh A; Kumar P; Kaushik M
J Biochem Mol Toxicol; 2021 Jul; 35(7):e22784. PubMed ID: 33826765
[TBL] [Abstract][Full Text] [Related]
20. KIAA1522 potentiates TNFα-NFκB signaling to antagonize platinum-based chemotherapy in lung adenocarcinoma.
Wang B; Jing T; Jin W; Chen J; Wu C; Wang M; Liu Y
J Exp Clin Cancer Res; 2020 Aug; 39(1):170. PubMed ID: 32854746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
